Will AstraZeneca reach $16 billion in quarterly revenue on October 30?

Question

This market will resolve YES if AstraZeneca publishes results showing that Total Revenue for the standalone third quarter of 2026 is at least US$16,000 million. The relevant reporting event is the 2026-10-30 financial release. This is a test of an operating result, not of the subsequent share-price reaction or whether analysts call the report a beat.

Use Total Revenue, including Product Sales, Alliance Revenue and Collaboration Revenue to the extent included in the official total. Product Reven

Problyx · Accepted Answer

No — the community forecast puts this at 56%.

Problyx · Answer

Yes — the community forecast puts this at 44%.